Methinks AI
Unlocking life-saving treatments potential
Unlocking life-saving treatments potential
Methinks AI is a digital health startup with a vision to provide universal and timely medical assistance for life-saving treatments globally, starting with a focus on stroke. Their AI medical imaging software is designed to perform stroke triage and unlock stroke treatment potential from non-contrast CTs. Backed by VC funding and recent recognition, including winning the EIC Accelerator of the European Commission and achieving two gold medals in the RSNA Kaggle competitions, Methinks AI is poised for rapid growth. The company, founded in 2016 and based in Spain, recently secured a €2.50M Convertible Note investment from the European Innovation Council in November 2023, further bolstering its potential to make a significant impact in the field of medical technology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Convertible Note | €2.50M | 1 |
|
13 Nov 2023 |
| Grant | €2.50M | 1 |
|
14 Oct 2022 |
| Seed Round | Unknown | 2 |
|
08 Aug 2020 |
No recent news or press coverage available for Methinks AI.
We care about your data, and we'd love to use cookies make your experience better.
